Potassium triiodide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Potassium triiodide
DrugBank Accession Number
DB14492
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 419.8117
Monoisotopic: 419.67712
Chemical Formula
I3K
Synonyms
  • Iodine aqueous
  • Lugol's iodine
  • Lugol's solution
  • Microiodide
  • Potassium triiodide

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololPotassium triiodide may increase the hyperkalemic activities of Acebutolol.
AceclofenacPotassium triiodide may increase the hyperkalemic activities of Aceclofenac.
AcemetacinPotassium triiodide may increase the hyperkalemic activities of Acemetacin.
Acetylsalicylic acidPotassium triiodide may increase the hyperkalemic activities of Acetylsalicylic acid.
AlclofenacPotassium triiodide may increase the hyperkalemic activities of Alclofenac.
AliskirenPotassium triiodide may increase the hyperkalemic activities of Aliskiren.
AmilorideThe risk or severity of hyperkalemia can be increased when Potassium triiodide is combined with Amiloride.
AminophenazonePotassium triiodide may increase the hyperkalemic activities of Aminophenazone.
AmiodaronePotassium triiodide may increase the hyperkalemic activities of Amiodarone.
AmlodipinePotassium triiodide may increase the hyperkalemic activities of Amlodipine.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
International/Other Brands
Lugol's solution
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
CitraNatal 90 DHAPotassium triiodide (150 ug/1) + Ascorbic acid (120 mg/1) + Calcium citrate tetrahydrate (160 mg/1) + Cupric oxide (2 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (90 mg/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (20 mg/1) + Riboprine (3.4 mg/1) + Thiamine chloride (3 mg/1) + Vitamin D (400 [iU]/1) + Zinc oxide (25 mg/1) + alpha-Tocopherol acetate (30 [iU]/1)TabletOralMission Pharmacal2010-02-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
CitraNatal 90 DHAPotassium triiodide (150 ug/1) + Ascorbic acid (120 mg/1) + Calcium citrate tetrahydrate (160 mg/1) + Cupric oxide (2 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (90 mg/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (20 mg/1) + Riboprine (3.4 mg/1) + Thiamine chloride (3 mg/1) + Vitamin D (400 [iU]/1) + Zinc oxide (25 mg/1) + alpha-Tocopherol acetate (30 [iU]/1)TabletOralMission Pharmacal2010-02-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
T66M6Y3KSA
CAS number
12298-68-9
InChI Key
DKNPRRRKHAEUMW-UHFFFAOYSA-N
InChI
InChI=1S/I3.K/c1-3-2;/q-1;+1
IUPAC Name
potassium triiodan-2-uide
SMILES
[K+].I[I-]I

References

General References
Not Available
KEGG Drug
D00860
KEGG Compound
C08040
ChemSpider
94785
RxNav
1376155
ChEBI
5948
Wikipedia
Lugol%27s_iodine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Unknown StatusDiagnosticEndoscopists'Subjective Assessments / Image Quality of Early Esophageal Squamous Neoplasia1
3Not Yet RecruitingTreatmentHyperthyroidism1
3TerminatedPreventionHeart Failure1
2CompletedScreeningImage Quality / Irritation of the Mucous Membranes1
2CompletedTreatmentMalignant Lymphomas1
2TerminatedTreatmentNon-Hodgkin's Lymphoma (NHL)1
Not AvailableCompletedNot AvailableGraves Diseases1
Not AvailableRecruitingPreventionEsophageal Squamous Cell Neoplasm1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP2.04ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity40.02 m3·mol-1ChemAxon
Polarizability16.55 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on July 09, 2018 19:43 / Updated on June 12, 2020 16:53